跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FLURAZEPAM 15MG CAPSULE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FLURAZEPAM 15MG CAPSULE
Authorized
STANDARD
FLURAZEPAM 15MG CAPSULE
Laboratoires Confab Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b4cb29f130ef73f6
Company
Laboratoires Confab Inc
Type
Standard
Approval Details
Approval Id
b4cb29f130ef73f6
Drug Approval Canada Name
FLURAZEPAM 15MG CAPSULE
Product Name
FLURAZEPAM 15MG CAPSULE
Status
Cancelled Pre Market
Status Date
2021-04-09
Din
02232656
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Targeted (CDSA IV)
Ahfs
28:24.08
Atc Original
N05CD01 FLURAZEPAM
Atc Name
n 05 cd 01
Aig Number
0108704002
Company Name
Laboratoires Confab Inc
Company Address
4355 Boul. Sir Wilfrid Laurier, St-Hubert, Quebec, Canada, J3Y 3X3
Company Detail Path
/organization/laboratoires-confab-inc
Company Information
Pharmaceutical Company Name
Laboratoires Confab Inc
Country Name
Canada
Province Name
Quebec
City Name
saint-hubert,quebec,country_ca
Address
4355 boul Sir-Wilfrid-Laurier
Active Ingredients
FLURAZEPAM HYDROCHLORIDE
15 MG / CAP
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b4cb29f130ef73f6
Type
Standard
Back to Health Canada Approvals